|
KMID : 0191120180330270075
|
|
Journal of Korean Medical Science
2018 Volume.33 No. 27 p.75 ~ p.75
|
|
|
Prevalence of BRAFV600E Mutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in a BRAFV600E Prevalent Area
|
|
Kim Hye-Reen
Kim Bo-Hyun
Kim Young-Keum
Kim Jeong-Mi
Oh Seo-Young
Kim Eun-Heui
Lee Min-Jin
Kim Jong-Ho
Jeon Yun-Kyung
Kim Sang-Soo
Lee Byung-Joo
Kim Yong-Ki
Kim In-Joo
|
|
|
Abstract
|
|
|
Background: BRAFV600E mutation status and prevalence of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) has not yet been reported in Korea. The aim of this study was to investigate the significance of the BRAFV600E mutation in the follicular variant of papillary thyroid carcinoma (FVPTC) and to determine the prevalence of NIFTP in BRAFV600E mutation-prevalent Korean patients.
Methods: This study retrospectively analyzed 1,417 consecutive patients who underwent total thyroidectomy with routine prophylactic central lymph node dissection for papillary thyroid carcinoma (PTC). BRAFV600E mutation analysis was performed routinely using multiplex polymerase chain reaction by applying dual priming oligonucleotide. Clinicopathological characteristics and ultrasonographic findings were compared between BRAFV600E mutation-positive and -negative groups for FVPTC. Pathologists reviewed the pathology slides according to consensus diagnostic criteria for the encapsulated FVPTC and NIFTP.
Results: The prevalence of the BRAFV600E mutation in all subtypes of PTC was 61.0% (861/1,411). FVPTC presented a BRAFV600E mutation rate of 27.3%. The FVPTC patients with BRAFV600E mutation were older than those with no BRAFV600E mutation (P = 0.021). The prevalence of NIFTP was 0.18% among all PTC patients (2/1,411) and the proportion of NIFTP among FVPTC was 9.1% (2/22).
Conclusion: The BRAFV600E mutation is prevalent in Korean patients with FVPTC in a region with high frequency of the BRAFV600E mutation and very low prevalence of NIFTP compared with that reported in western studies.
|
|
|
KEYWORD
|
|
|
Thyroid Carcinoma, B-type Raf (BRAF), Follicular Variant, Papillary Carcinoma, NIFTP
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|